Quent Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Quent Capital's NVO Position: Q3 2026 in Review
Quent Capital reduced its Novo Nordisk (NVO) stake by 4.8% in Q3 2026, selling an estimated $1.71K and leaving 737 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #994.
Quent Capital first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $62.5K in Q4 2024. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Quent Capital held 737 shares of Novo Nordisk worth $27.9K as of Q3 2026.
- Quent Capital sold 37 Novo Nordisk shares in Q3 2026, an estimated $1.71K.
- Novo Nordisk made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #994 holding.
- Quent Capital first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
- Quent Capital's Novo Nordisk position peaked at $62.5K in Q4 2024.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.